REFERENCES
- Trussell J, Wynn LL. Reducing unintended pregnancy in the United States. Contraception 2008;77:1–5.
- Henderson D. A third of women in UK who have an unintended pregnancy blame contraceptive failure. BMJ 2009;339:b2975.
- Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404.
- Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998–2007.
- National Collaborating Centre for Women's and Children's Health. Long-acting reversible contraception. NICE Guideline CG30 2005. Accessed 3 July 2014 from: http://www.nice.org.uk/Guidance/CG30
- Office for National Statistics. Contraception and sexual health report, 2008-09. Opinion Survey Report No. 41. Accessed 3 July 2014 from: http://www.ons.gov.uk/ons/search/index.html?&newquery = Contraception+ and+Sexual++Health+Report&pageSize = 100& applyFilters=true&sortBy=content-type&sort Direction = ASCENDING
- National Institute for Health and Care Excellence. Long-acting reversible contraception (LARC). NICE implementation uptake report 2010. Accessed 3 July 2014 from: http://www.nice.org.uk/media/67F/C5/UptakeReportCG30LARC.pdf
- Blak BT, Thompson M, Dattani H., Bourke A. Generalisability of The Health Improvement Network (THIN) database: Demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011;19:251–5.
- Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007;16:393–401.
- Stuart-Buttle CD, Read JD, Sanderson HF, et al. A language of health in action: Read Codes, classifications and groupings. Proc AMIA Annu Fall Symp 1996:75–9.
- First Databank. MULTILEX 2012. Accessed 3 July 2014 from: http://www.fdbhealth.co.uk/solutions/multilex/.
- Cea Soriano L, Wallander MA, Andersson SW, et al. Study of long-acting reversible contraceptive use in a UK primary care database: Validation of methodology. Eur J Contracept Reprod Health Care 2014;19:22–8.
- Cea-Soriano L, Garcia-Rodriguez LA, Machlitt A, Wallander MA. Use of prescription contraceptives in the UK general population: A primary care study. BJOG 2014;121:53–60; discussion: 60–1.
- Sexual Health Balanced Scorecard. Rate GP prescribed long acting reversible contraception (LARC) (and by LARC type) 2012/13 (and since 2007/08). Accessed 3 July 2014 from: http://www.apho.org.uk/default.aspx?RID = 74107&TYPE = FILES
- French RS, Mercer CH, Johnson AM, et al. Use of contraceptive services in Britain: Findings from the second National Survey of Sexual Attitudes and Lifestyles (Natsal-2). J Fam Plann Reprod Health Care 2009;35:9–14.
- The NHS Information Centre. NHS Contraceptive Services: England, 2009/10. Accessed 3 July 2014 from: http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles/contraception/nhs-contraception-services-england-2009-10
- Wellings K, Zhihong Z, Krentel A, et al. Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Contraception 2007;76:208–14.
- Department of Health. Abortion statistics, England and Wales: 2013. Accessed 3 July 2014 from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/319460/Abortion_Statistics__England_and_Wales_2013.pdf
- Blumenthal PD, Voedisch A, Gemzell-Danielsson K. Strategies to prevent unintended pregnancy: Increasing use of long-acting reversible contraception. Hum Reprod Update 2011;17:121–37.
- Haimovich S. Profile of long-acting reversible contraception users in Europe. Eur J Contracept Reprod Health Care 2009;14:187–95.
- Bharadwaj P, Akintomide H, Brima N, et al. Determinants of long-acting reversible contraceptive (LARC) use by adolescent girls and young women. Eur J Contracept Reprod Health Care 2012;17:298–306.
- Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Intrauterine contraception. Accessed 3 July 2014 from: http://www.fsrh.org/pdfs/CEUGuidanceIntrauterineContraceptionNov07.pdf
- Middleton AJ, Naish J, Singer N. General practitioners’ views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK. Eur J Contracept Reprod Health Care 2011;16:311–8.
- Black K, Lotke P, Buhling KJ, Zite NB. A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women. Eur J Contracept Reprod Health Care 2012;17:340–50.